Purpose: We assessed the value of adding a breath-hold, black-blood, ‰uid-attenuated, inversion recovery (BH-BB-FLAIR) sequence with a small motion-probing gradient (b＝10 s/mm 2 ) using superparamagnetic iron oxide (SPIO) to our present studies that utilize SPIO to detect hepatocellular carcinoma (HCC). We used inversion recovery (IR) in a FLAIR sequence to suppress signals from cysts and a low b-value to suppress vessel signals and provide higher signal to noise than that using high b-value diŠusion-weighted imaging. Use of SPIO is expected to reduce the signal in both normal liver parenchyma and in most benign lesions.
Introduction
DiŠusion-weighted imaging (DWI) has been used primarily to evaluate intracranial areas, particularly after acute ischemic stroke. 1, 2 However, body DWI has recently been used in other areas of the body, including the abdomen, e.g., liver and kidney; pelvis, e.g. prostate, uterus, colon, and rectum; lymph nodes; neck; and whole body. [3] [4] [5] [6] [7] [8] [9] [10] DWI is useful for discriminating malignant tumors by demonstrating a decrease in the apparent diŠusion coe‹cient (ADC) that is probably attributable to high tumor cellularity. 5, [11] [12] [13] Current DWI methods employ either a large motion-probing diŠusion gradient (high b-factor) to emphasize the eŠect of diŠusion or a small gradient (low b-factor) to suppress the signals from vessels. Although DWI with a high b-factor is reported useful for detecting tumors in the liver, 14 its disadvantages include image obscuration from artifacts and distortion and prolonged scan time when using Fig. 1 . Concept of breath-hold, black-blood, ‰uid-attenuated inversion recovery (BH-BB-FLAIR) using superparamagnetic iron oxide (SPIO) for hepatocellular carcinoma (HCC). Upper route: Black blood (small motionprobing gradient) suppresses the signals from vessels with a high signal-to-noise ratio (SNR) and less distortion. Middle route: FLAIR suppresses the signals from cysts. Lower route: SPIO reduces the signal in the liver parenchyma and decreases the signal in hemangiomas. This simultaneous use causes the signal from HCC to stand out. 50 M. Matsushima et al.
Magnetic Resonance in Medical Sciences
a respiratory-triggered or multiple averaging technique with free breathing. 10, 15 DWI with a low b-factor is called black-blood T 2 -weighted (T 2 W) imaging because of the absence of vessel signal in the image. The sensitivity of breathhold, black-blood, T 2 W, single-shot, spin-echo, echo-planar imaging of the liver using a small motion-probing diŠusion gradient (BH-BB-T 2 W EPI) has been reported superior to that of fast spinecho (FSE)-based T 2 W imaging in detecting focal liver lesions. [16] [17] [18] Suppression of signals from vessels facilitates lesion identiˆcation. BH-BB-T 2 W EPI can be used to visualize cysts and hemangiomas as areas of hyperintensity as well as to visualize solid liver lesions. Especially following administration of superparamagnetic iron oxide (SPIO), residual signals are mainly from cysts and solid lesions. Suppression of the signals from cysts using a ‰uid-attenuated inversion recovery (FLAIR) pulse may make identifying solid lesions even easier. We used a low b-value to suppress vessel signals and provide a higher signal-to-noise ratio (SNR) than that with high b-value DWI. Use of SPIO reduced the signals in normal liver parenchyma and in most benign lesions. Part of this method has already been reported. 19 Figure 1 illustrates the concept underlying this method. The eŠects of black blood, FLAIR pulse, and SPIO make the signal from HCC stand out. We assessed the value of adding the BH-BB-FLAIR sequence with a small motion-probing gradient (MPG; b＝10 s/mm 2 ) using SPIO to our present SPIO-mediated studies to detect hepatocellular carcinoma (HCC).
Materials and Methods

Imaging protocols
All magnetic resonance (MR) imaging examinations were performed on a 1.5-tesla system (Excelart Vantage TM , Toshiba, Tokyo, Japan) with a maximum gradient speciˆcation of 30 mT/m and a slew rate of 130 mT/m/ms, using a 10-channel body phased-array coil. We obtained BB-BH-FLAIR images using a Stejskal-Tanner sequence by single-shot, spin-echo-type EPI and applied the MPG in 6 orientations following the acquisition of b＝0 images. MPG was applied for 6 directions. The scan time was 24 s. A parallel imaging technique, SENSE (sensitivity encoding), was used with an acceleration factor of 2. 20 The inversion time (IR) for FLAIR was determined to be 920 ms, which was optimized on theˆrst volunteer study. In each patient, an axial BB-BH-FLAIR image was obtained prior to intravenous administration of SPIO (Resovist; Bayer, Osaka, Japan). The SPIO was administered manually in approximately one minute at a dose of 0.016 mL/kg, which corresponded to 0.45 mg/kg of Fe. The detailed method of SPIO BH-BB-FLAIR imaging has been reported. 19 Before and 5 min after administering SPIO, we obtained axial gradient-echo, dual-echo, T 1 -weighted (T 1 W), and FSE T 2 W images during a single breath-hold and fat-suppressed respiratory-triggered FSE T 2 W images as well as axial gradientecho T 2 *-weighted (T 2 *W) images using the same slice thickness and interslice gap as those for BB-BH-FLAIR images. We obtained axial gradientecho, dual-echo, T 1 -weighted (T 1 W), and FSE T 2 W images during a single breath-hold; fat-suppressed respiratory-triggered FSE T 2 W images; and axial gradient-echo T 2 *-weighted (T 2 *W) images, all using the same slice thickness and interslice gap as those for BB-BH-FLAIR images.
Following intravenous administration of SPIO, we obtained T 2 W and T 2 *W, BB-BH-FLAIR, fatsuppressed T 2 W, and dual-echo T 1 W images in this order. Table 1 details BH-BB-FLAIR and other imaging parameters.
The CT arterioportography (CTAP) and CT during hepatic arteriography (CTHA) were performed on single-or multi-detector (4-or 16-slice) CT scanners (Asteion or Aquilion, Toshiba, Tokyo, Japan) using a 5-mm table feed in a craniocaudal direction. Acquisition of data of the portal-dominant part was started 30 to 40 s after an initial injection of 50 to 90 mL of contrast medium (approximately 120 mgI/mL), with a ‰ow of 2 to 3 mL/s via a catheter placed in the superior mesenteric artery and using an automatic power injector. Acquisition of data of the arterial-dominant part was started 8 s following the initial injection of 12 to 50 mL of contrast medium (350 or 370 mgI/mL), with a ‰ow of 0.9 to 1.5 mL/s via catheter in the common hepatic artery or bilateral hepatic arteries using an automatic power injector. The quantity and speed of injection were adjusted according to the patient's weight and renal function. One breath-hold acquisition was obtained during each pass through the liver.
Clinical studies Patients
We obtained study approval from our hospital's medical ethics committee and informed consent from all subjects. We retrospectively identiˆed 20 patients with HCC who had undergone MR imaging comprising sequentially acquired SPIO-enhanced MR imaging and combined CTHA and CTAP at our hospital from July 2005 to February 2007. From these, we selected 19 patients aged 57 to 84 years (mean±standard deviation [SD] 66.4± 7.03 years) with a time interval between the 2 imaging modality studies ranging within 3 weeks (1 to 17 days, mean interval, 5.32 days). The one patient was excluded because of a 5-month interval between studies. None of the study patients had liver masses other than HCC, regenerating nodules, dysplastic nodules, or hepatic cysts. All patients had some nodules smaller than 3 cm in diameter. Establishing the reference standard By consensus, 2 radiologists from the Nagoya University Graduate School of Medicine with 3 and 21 years' clinical experience in abdominal MR imaging determined as HCC-nodules that were apparent on CTAP in areas of partial or entire hypodensity that indicated absent intranodular portal supplies and that appeared on CTHA as areas of partial or entire hyperdensity that indicated increased intranodular arterial blood supply. Both radiologists retrospectively reviewed all MR images with an awareness of the CTHA and CTAP results and conˆrmed the presence of HCC nodules (n＝38) on MR images. Because nodules exceeding 3 cm in diameter were obvious in all images, they were excluded from this study.
Set-up of image sets for evaluation
From all images (32 slices×8 sequences＝256 images), slice levels passing around the center of HCC lesions were selected from each sequence. Thirtytwo positive slices included 27 with only one lesion, four with two, and one with three. In contrast, 60 slice levels from other subjects selected similarly at each positive slice level conˆrmed the absence of HCC. These images were divided into 2 image sets. One set without SPIO-BH-BB-FLAIR was included in the pre-and post-dual-echo T 1 W, T 2 W, and post-T 2 *W images, whereas the other set with SPIO-BH-BB-FLAIR was added to the post-SPIO BH-BB-FLAIR images to the former image set.
Image analysis
Six experienced radiologists with 3 to 14 years' clinical experience (mean, 8 years) who were blinded to other imagingˆndings andˆnal diagnoses interpreted the images in only one slice from each sequence. Each observer independently assessed the image sets at intervals of at least 4 weeks. Reading order was randomized, and the readers read half of each of the 2 image sets at each reading to avoid reading the same nodule twice at the same time. The readings were performed on a high-resolution liquid crystal display (2M-LCD×2) monitor on a DICOM viewer.
Each observer reported the location of suspected malignant nodules by rough sketching and indicated the conˆdence level for nodule presence using a continuous rating scale from 0 (deˆnite absence) to 1 (deˆnite presence) of malignant nodules. Malignant nodules were deˆned as either a focal discrete, nodular area of high signal intensity relative to the surrounding liver parenchyma on BH-BB-FLAIR images obtained after SPIO administration or as a nodular area indicating lower uptake of SPIO than the surrounding liver parenchyma on T 2 W and T 2 * W images. However, each observer determined theˆnal diagnosis, and no further evaluation was performed to diŠerentiate HCC from other possible malignant tumors.
Data analysis
Each observer's detection performance was assessed using receiver operating characteristic (ROC) analysis in which a binormal ROC curve wasˆtted to the individual observer's conˆdence rating data from each reading session using a maximum likelihood estimation (MLE). We used the Metz LABROC4 algorithm 21 to obtain MLEs of binomial ROC curves from the continuous ordinalscale rating data. The area under the binomial ROC curve, Az, was used as an index of observer performance. To summarize the ROC curves for each test, the average ROC curves were obtained by averaging the binormal slope and intercept parameters of the individual observer's ROC curves for each image set.
Our experimental design required statistical analysis of the diŠerences between the 2 image sets. We performed analysis of variance (ANOVA) on the pseudo-values of Az computed using the jackknifeanalysis method proposed by Dorfman's group 22 that was selected as the Dorfman-Berbaum-Metz (DBM) method. 23 We calculated localization accuracy rate, probability of correct localization (PCL), and ratio of all images of malignant nodules correctly indicated on rough observer sketches regardless of conˆdence rates. We then estimated 95z conˆdence intervals using the maximum likelihood method for the binormal model. Pº0.05 was accepted as signiˆ-cant.
Results
Quality of all images acquired using BH-BB-FLAIR was considered readable with less susceptible to artifacts and distortion.
According to our estimation, images obtained with BH-BB-FLAIR following SPIO administration depicted 33 of 38 HCC nodules as areas of high signal and the remainingˆve as areas of iso-or low signal; the nodules were apparently not detected using other MR sequences (Figs. 2-4) . Five nodules shown as areas of partial hypodensity on CTAP and partial hyperdensity on CTHA were presumed to be on the step of well diŠerentiated HCC during hepatocarcinogenesis. On the images obtained with BH-BB-FLAIR after SPIO administration, three of these 5 nodules appeared as areas of high signal (Fig. 4) , the other two were not shown, and the signal of the cyst was extinguished 
inversion recovery (BH-BB-FLAIR) image. (e) Computed tomographic (CT) arterioportography (CTAP). (f) CT during hepatic arteriography (CTHA). Large classical HCC (arrowheads, a-f) in Segment 8 and small HCC in Segment 4 (arrows, c-f) are depicted on CTAP (e) and CTHA (f).
The large lesion is apparent on all images, whereas the nodule in Segment 4 is so small that it is di‹cult to identify on conventional magnetic resonance (MR) imaging (a-c). Conversely, this small nodule is distinct and can be easily identied on BH-BB-FLAIR (d). (Fig. 3) .
We observed signiˆcant diŠerences in Azs between the 2 image sets. Table 2 lists the results of the DBM ANOVA conducted on Azs for the 2 sets. This overall ANOVA showed statistically reliable eŠects of the 2 image sets on reader diagnostic performances ( Pº0.05). Statistically reliable diŠer-ences in diagnostic performance were found among the 92 cases ( Pº0.001). No statistically reliable diŠerences were found among the 6 observers ( P＝ 0.6126). Figure 5 depicts the average ROC curves for the 2 image sets, showing the curve for the set obtained with BH-BB-FLAIR after SPIO administration to be superior to that of the set without.
Although some observers noted statistically reliable diŠerences in PCL in the 2 image sets (Fig. 6) , the relationship between PCL values and the 2 sets diŠered among the 6 observers, and no general tendency was recognized regarding this relationship.
Discussion
Identifying the exact number and location of HCC nodules optimizes treatment strategies. CTAP and CTHA have high detection rates for HCC, and their combined use has beenˆrmly established for successfully diagnosing HCC 24 and enables evaluation of the blood supply for histologically grading HCC malignancy. 25 Consequently, CTHA and CTAP have been adopted as reference standards. Nevertheless, it is di‹cult to justify their use for screening because their disadvantages include radiation exposure, risk of allergic reaction and anaphylactic shock associated with using an iodine contrast material, invasiveness of selective injection in the superior mesenteric and celiac artery, and bleeding from the puncture canal.
SPIO is a tissue-speciˆc MR imaging contrast medium that is taken up by KupŠer cells in the liver and has thus been used to detect hepatic tumors. . Because the signal from this lesion is low and the signals from multiple cysts are obvious on (b), it is di‹cult to identify the lesion. In (d), similarly to (c), the lesion shows high intensity, and the multiple cysts show a decrease in signal. However, because this nodule shows much higher intensity than the surrounding parenchyma, it is more easily identiˆed on BH-BB-FLAIR (d) than on (c). The area of high intensity on BB-BH-FLAIR (arrowhead, d) is presumed to be edema or non-speciˆc in‰ammation of the Glisson's sheath. 54 M. Matsushima et al.
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SPIO-enhanced MR imaging re‰ects numbers and function of KupŠer cells. It has been reported that the number of KupŠer cells decreases in HCC nodules and that SPIO-enhanced MR imaging is useful for estimating HCC histological grading. 26, 27 However, the detection rate of small HCC nodules on SPIO-enhanced MR imaging is reported to be inferior to that of other dynamic modalities, 28 possibly attributable, in part, to the residual signals of vessels and cysts. Therefore, the detection rate of small HCCs using SPIO-enhanced MR imaging must be improved. DiŠusion-weighted imaging of the liver is divided roughly into a method utilizing a high b-factor (bÀ400) 3, 13 and one employing a low b-factor (black-blood liver imaging) (bº100). [16] [17] [18] Use of a high b-factor may permit diŠerentiation of benign from malignant tumors to further estimate the degree of HCC diŠerentiation but may be ineŠec-tive for detecting small lesions resulting from gross artifacts caused by breathing and peristalsis as well as severe distortion from the boundary surface of air to parenchyma. 29 The method employing a low b-factor (small MPG) is less susceptible to artifacts and distortion. 29, 30 In addition, because many liver tumors and vessels have high signal on FSE T 2 W images, it is di‹cult to distinguish small tumors from the signals of the portal and hepatic veins in the liver. Distinguishing small tumors from these veins is certainly possible when comparing contiguous slices in up and down views, but it is very timeconsuming. Suppressing vessel signal with a small MPG makes detection of a small lesion easier. 18 Well diŠerentiated HCC is an early stage of multistep hepatic carcinogenesis. 31, 32 Although DWI using a high b-value is expected to be the optimal method to detect malignancies, such as tumors in other regions, DWI does not clearly depict well differentiated HCCs. 13 Perhaps this results from the lack of a T 2 shine-through eŠect as well as a similar ADC as that of the surrounding liver parenchyma. 33 The T 1 value of well diŠerentiated HCC is reported shorter than that of the surrounding liver parenchyma. 34 Therefore, as we expected, well differentiated HCCs can be visualized on BH-BB-FLAIR images, which aŠect T 2 shine-through and the character of a T 1 W image. However, it is difcult to detect some well diŠerentiated HCCs on BH-BB-FLAIR because they have T 1 and T 2 values resembling those of the surrounding liver parenchyma and the uptake ability of SPIO. Treatment for HCC includes resection; transplantation; regional therapeutic procedures, such as transcatheter arterial infusion therapy or transcatheter arterial embolization (TAE); 35 percutaneous ethanol instillation; 36 chemotherapy; and radiofrequency ablation. 37 Because therapy is chosen based on the number and range of nodules, it is important to detect small or well diŠerentiated HCC nodules and determine possible malignancy. It is also necessary to diŠerentiate benign lesions, such as cysts and hemangiomas, that are often seen in the liver. In this study, we applied an IR pulse in FLAIR to suppress signals from cysts. Simple cysts Table 2 . Area under the ROC curve (Az)＝estimated means of Az ±95z conˆdence intervals for each image set. Fig. 6 . Localization accuracy rates ( P CL 's)±their 95z conˆdence intervals for each observer and for each image set. P CL is the ratio of all malignant nodule images having nodules correctly reported on a rough sketch by the observer regardless of conˆdence rate. The 95z conˆdence intervals were estimated using the maximum-likelihood method for the binormal model. 
can be diagnosed by comparing T 1 W, T 2 W, and gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA)-enhanced images; however, identifying solid tumors in many small cysts is sometimes di‹cult, such as in the case shown in Fig. 3 . Consequently, BH-BB-FLAIR can be used to diŠeren-tiate small cysts and solid lesions with conˆdence rather than comparing the numerous images obtained on many sequences. Although we did not include cavernous hemangioma in this study, in our experience, it showed a decrease in signal intensity in BH-BB-FLAIR images obtained after SPIO administration compared with those acquired before SPIO. Signals from hemangiomas are reportedly increased by SPIO in T 1 W images. 38 Although they have some T 1 W characteristics, BH-BB-FLAIR images require a relatively long echo time of 80 ms that causes signals from hemangiomas to decrease after the lesionˆlls with SPIO particles as a result of T 2 * -shortening eŠect. Most HCC nodules develop in patients with liver cirrhosis. However, in late-stage cirrhosis, uneven uptake of iron oxide particles caused by the decreased activity of KupŠer cells results in poor lesion conspicuity on SPIO-enhanced MR imaging. 27, 39, 40 However, SPIO-enhanced MR imaging with BH-BB-FLAIR suppresses signal obstacles and synergistically utilizes the diŠerence between T 1 and T 2 values to improve lesion conspicuity.
Our study has several limitations. First, the design was retrospective, and the patient population was small. Second, the gold standard of this study was the consensus interpretations with the CTHA and CTAP results, and all lesions were not histopathologically conˆrmed; therefore, the actual sensitivity of detecting HCC could be overestimated by a reduced number of false-negative lesions. Third, BH-BB-FLAIR imaging provides rather blurred images, low spatial resolution, and distortion owing to the use of echo-planar imaging. Conclusions BH-BB-FLAIR imaging after SPIO administration is an excellent method for visualizing HCC nodules. Interpreting images thus obtained along with other SPIO-mediated images improved detection of HCC, and addition of BH-BB-FLAIR adds only 24 s to existing protocols for SPIO-mediated studies. The resultant suppression of signals from vessels and cysts makes it easy for radiologists to identify lesions.
